Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial [F-18] Fluoroestradiol (FES) PET Imaging to Evaluate Endocrine-targeted Therapy

NCT04692103 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04692103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04692103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial [F-18] Fluoroestradiol (FES) PET Imaging to Evaluate Endocrine-targeted Therapy
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 10, 2021
Completion date
April 30, 2041
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor positive, primary or recurrent breast carcinoma, stage iv breast cancer ajcc v6 and v7